Jones Hill Capital »

Nuvalent Inc-a shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Nuvalent Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $31M 301k 102.45

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)
Terns Pharmaceuticals (TERN)
Bicara Therapeutics (BCAX)
Biosante Pharmaceuticals (ANIP)
Ultragenyx Pharmaceutical (RARE)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)
Argenx Se Sponsored Adr (ARGX)
Fulcrum Therapeutics (FULC)
Vir Biotechnology (VIR)
Nuvation Bio Com Cl A (NUVB)

View all positions for Jones Hill Capital

Top funds holding Nuvalent Inc-a

Deerfield Management Company
FMR
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
RA Capital Management
Vanguard Portfolio Management
Wellington Management Company
Vanguard Capital Management
State Street Corporation
Perceptive Advisors
Polar Capital Holdings
Deep Track Capital
T. Rowe Price Investment Management
Geode Capital Management

View all funds holding Nuvalent Inc-a